Adam M. Huber

Adam M. Huber

Pediatric Rheumatology

5980 University Ave
Halifax, NS, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 144 publications

Dr. Tsai et al reply.

Dr. Tsai et al reply.

Journal: The Journal of rheumatology

Published: August 15, 2026

Olfactomedin-4+ neutrophils exacerbate intestinal epithelial damage in Clostridioides difficile infection.

Olfactomedin-4+ neutrophils exacerbate intestinal epithelial damage in Clostridioides difficile infection.

Journal: Infection and immunity

Published: January 07, 2026

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Journal: Arthritis care & research

Published: December 08, 2025

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome Measures.

Journal: Arthritis care & research

Published: December 08, 2025

Effective Performance of the 2022 American College of Rheumatology/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Pediatric Patients: An ARChiVe Study.

Effective Performance of the 2022 American College of Rheumatology/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Pediatric Patients: An ARChiVe Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 24, 2025

Effect of Treatment Changes on Health-Related Quality of Life in Canadian Children With Juvenile Idiopathic Arthritis: Results From ReACCh-Out and CAPRI.

Effect of Treatment Changes on Health-Related Quality of Life in Canadian Children With Juvenile Idiopathic Arthritis: Results From ReACCh-Out and CAPRI.

Journal: The Journal of rheumatology

Published: August 25, 2025

"I'm in pain, and I'm not faking it": A qualitative exploration of the reactions of youth with juvenile idiopathic arthritis and their caregivers to pain-related stigma.

"I'm in pain, and I'm not faking it": A qualitative exploration of the reactions of youth with juvenile idiopathic arthritis and their caregivers to pain-related stigma.

Journal: Arthritis research & therapy

Published: June 14, 2025

Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force.

Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force.

Journal: Annals of the rheumatic diseases

Published: March 07, 2025

Assessing the impact of the iPeer2Peer program for adolescents with juvenile idiopathic arthritis: a mixed-methods randomized controlled trial.

Assessing the impact of the iPeer2Peer program for adolescents with juvenile idiopathic arthritis: a mixed-methods randomized controlled trial.

Journal: Pediatric rheumatology online journal

Published: September 25, 2024

Evaluating Renal Disease in Pediatric-Onset Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome.

Evaluating Renal Disease in Pediatric-Onset Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 04, 2024

Exploring Pain Adaptation in Youth With Juvenile Idiopathic Arthritis: Identifying Youth and Parent Resilience Resources and Mechanisms.

Exploring Pain Adaptation in Youth With Juvenile Idiopathic Arthritis: Identifying Youth and Parent Resilience Resources and Mechanisms.

Journal: Arthritis care & research

Published: April 05, 2024

Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.

Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.

Journal: Arthritis care & research

Published: March 27, 2024

Showing 1-12 of 144

Last Updated: 09/26/2026